Company: XOMAP
Filing Date: 2025-10-03
Form Type: 424B5
Source: 0001193125-25-230393
Chunk: 20

Company: XOMA Royalty Corp
Filing Date: 2025-10-03
Form: 424B5
Chunk 20
---
 included in the documents that we incorporate by reference herein and therein.

In addition, past
financial and/or operating performance is not necessarily a reliable indicator of future performance, and you should not use our historical performance to anticipate results or future period trends. We can give no assurances that any of the events
anticipated by the forward-looking statements will occur or, if any of them do, what impact they will have on our results of operations and financial condition. Except as required by law, we undertake no obligation to publicly revise our
forward-looking statements to reflect events or circumstances that arise after the filing of this prospectus supplement or any free writing prospectus that we have authorized for use in connection with this offering, or documents incorporated by
reference herein and therein, that include forward-looking statements.

S-15

USE OF PROCEEDS

We intend to use the net proceeds from this offering to fund future dividends and the remaining net proceeds to acquire additional potential royalty and
milestone revenue streams, for working capital and other general corporate purposes.

S-16

DESCRIPTION OF SERIES B PREFERRED STOCK AND THE DEPOSITARY SHARES The following is a summary of the material terms and provisions of the Series B Preferred Stock and the depositary shares. The statements below describing our Series B Preferred Stock are in all respects subject to and qualified in their entirety by reference to the applicable provisions of our articles of incorporation, including the certificate of designation establishing the Series B Preferred Stock, and our bylaws, each of which is available from us as described in the “Where You Can Find More Information” section of this prospectus supplement and is incorporated by reference in this prospectus supplement. See also “Description of Depositary Shares” in the accompanying prospectus. This description of the particular terms of the Series B Preferred Stock and the depositary shares supplements the description of the general terms and provisions of our preferred stock set forth in the accompanying prospectus under “Description of Capital Stock—Preferred Stock” and under “Description of Depositary Shares.” For a description of the Common Stock into which the Series B Preferred Stock is convertible, see “Description of Capital Stock—Common Stock” in the accompanying prospectus. General Our current authorized capital stock consists of 277,333,332 shares of Common Stock, par value $0.0075 per share, and 1,000,000 shares of preferred stock, par value $0.05 per share. Shares of preferred stock and related depositary shares may be offered and sold from time to time, in one or more series, as